TABLE 1.
Group (n) | MIC (μg/ml)a
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Levofloxacin
|
Cefpirome
|
Ceftazidime
|
Gentamicin
|
Meropenem
|
||||||
50% | 90% | 50% | 90% | 50% | 90% | 50% | 90% | 50% | 90% | |
Susceptible (30)b | 0.5 | 4 | 8 | 16 | 2 | 8 | 2 | 4 | 1 | 2 |
Resistant | ||||||||||
Ceftazidime (26) | 2 | 4 | 64 | >128 | 128 | >128 | 0.5 | 4 | 1 | 4 |
Gentamicin (21) | 8 | >32 | 8 | 16 | 8 | 8 | 32 | >64 | 1 | 4 |
Meropenem (24) | 1 | 2 | 8 | 8 | 4 | 8 | 1 | 4 | 8 | 16 |
Miscellaneous (23)c | 4 | 32 | 128 | >128 | 128 | >128 | 32 | 64 | 4 | 32 |
50% and 90%, MIC50R and MIC90, respectively.
Susceptible to cephalosporins, gentamicin, and meropenem.
Resistant to cephalosporins, gentamicin, and meropenem (n = 10); resistant to gentamicin and cephalosporins and susceptible to meropenem (n = 12); gentamicin susceptible, resistant to cephalosporins and meropenem (n = 1).